RankingsPricing
  1. JP-listed companies
  2. PhoenixBio Co.,Ltd.
  3. Financials
  4. Repayments of term debt

PhoenixBio Co.,Ltd.JP:6190

Market cap
¥1.9B
P/E ratio
17.7x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndRepayments of term debt (Million JPY)YoY (%)
Mar 31, 2025-80+300.00%
Mar 31, 2024-20+706.05%
Mar 31, 2022-2-87.60%
Mar 31, 2021-20-23.07%
Mar 31, 2020-26-53.57%
Mar 31, 2019-56+0.00%
Mar 31, 2018-56-69.61%
Mar 31, 2017-184+245.26%
Mar 31, 2016-53+5.85%
Mar 31, 2015-50

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)